These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20066882)

  • 1. [Role of ACE-inhibitors in preventing atrial fibrillation relapses in normotensive patients].
    Belluzzi F; Sernesi L; Centola M; Perlini S
    Recenti Prog Med; 2009 Nov; 100(11):508-11. PubMed ID: 20066882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.
    Belluzzi F; Sernesi L; Preti P; Salinaro F; Fonte ML; Perlini S
    J Am Coll Cardiol; 2009 Jan; 53(1):24-9. PubMed ID: 19118720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.
    Salehian O; Healey J; Stambler B; Alnemer K; Almerri K; Grover J; Bata I; Mann J; Matthew J; Pogue J; Yusuf S; Dagenais G; Lonn E;
    Am Heart J; 2007 Sep; 154(3):448-53. PubMed ID: 17719288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
    Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial fibrillation as end point of hypertension. Can antihypertensive therapy prevent it?].
    Geller JC
    MMW Fortschr Med; 2003 Nov; 145(47):38-41. PubMed ID: 14725032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
    Healey JS; Morillo CA; Connolly SJ
    Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor blockers in the prevention of atrial fibrillation.
    Barra S; Silvestri N; Vitagliano G; Madrid A; Gaeta G
    Expert Opin Pharmacother; 2009 Jun; 10(9):1395-411. PubMed ID: 19466911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.
    Fogari R; Derosa G; Ferrari I; Corradi L; Zoppi A; Lazzari P; Santoro T; Preti P; Mugellini A
    Am J Hypertens; 2008 Sep; 21(9):1034-9. PubMed ID: 18566593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
    Lip GY; Frison L; Grind M
    J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
    Doğan A; Akçay S
    Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
    Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.